Baseline MUGA scans for patients with early-stage breast cancer receiving adjuvant chemotherapy

被引：0
|
作者：
Jeyakumar, A. S.
Dipenta, J.
Snow, S. L.
Rayson, D.
Thompson, K.
Theriault, C.
Younis, T.
机构：
[1] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[2] Dalhousie Univ, Dartmouth, NS, Canada
[3] Capital Hlth, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6087
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Adjuvant bisphosphonates for early-stage breast cancer
    Brufsky, Adam
    LANCET ONCOLOGY, 2011, 12 (07): : 610 - 611
  • [42] Is paclitaxel cost-effective for the adjuvant chemotherapy in early-stage breast cancer?
    Limwattananon, S
    Limwattananon, C
    Maoleekulpairoj, S
    Soparatanapaisal, N
    PHARMACOTHERAPY, 2005, 25 (10): : 1473 - 1473
  • [43] Re: Adjuvant chemotherapy in patients with early-stage ovarian cancer - Response
    Guthrie, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1169 - 1170
  • [44] Simulation modeling of the effects of adjuvant chemotherapy in early-stage breast cancer.
    Jayasekera, Jinani
    Schechter, Clyde B.
    Sparano, Joseph A.
    Isaacs, Claudine
    Gray, Robert James
    Cadham, Christopher
    Mandelblatt, Jeanne S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] A prospective assessment of variables contributing to reduced relative dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
    Shayne, M
    Culakova, E
    Wolff, D
    Poniewierski, M
    Lyman, GH
    Dale, DC
    Crawford, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S110 - S110
  • [46] Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
    Li, Yan
    Zhou, Yidong
    Mao, Feng
    Lin, Yan
    Zhang, Xiaohui
    Shen, Songjie
    Sun, Qiang
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (03) : 533 - 542
  • [47] Prospective validation of a risk model for first cycle neutropenic complications in early-stage breast cancer patients receiving adjuvant chemotherapy.
    Lyman, G. H.
    Kuderer, N. M.
    Crawford, J.
    Wolff, D. A.
    Culakova, E.
    Poniewierski, M. S.
    Dale, D. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S283 - S284
  • [48] Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
    Yan Li
    Yidong Zhou
    Feng Mao
    Yan Lin
    Xiaohui Zhang
    Songjie Shen
    Qiang Sun
    Breast Cancer Research and Treatment, 2020, 179 : 533 - 542
  • [49] Fatigue in early breast cancer patients receiving adjuvant postoperative chemotherapy
    Heras, P.
    Hatzopoulos, A.
    Kritikos, K.
    Kapouralos, A.
    Androutsos, N.
    BREAST, 2009, 18 : S70 - S70
  • [50] Energy Balance in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy
    Michelle N. Harvie
    I.T. Campbell
    A. Baildam
    A. Howell
    Breast Cancer Research and Treatment, 2004, 83 : 201 - 210
12345